These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 22259000

  • 1. Bezafibrate for primary biliary cirrhosis.
    Rudic JS, Poropat G, Krstic MN, Bjelakovic G, Gluud C.
    Cochrane Database Syst Rev; 2012 Jan 18; 1(1):CD009145. PubMed ID: 22259000
    [Abstract] [Full Text] [Related]

  • 2. Ursodeoxycholic acid for primary biliary cirrhosis.
    Rudic JS, Poropat G, Krstic MN, Bjelakovic G, Gluud C.
    Cochrane Database Syst Rev; 2012 Dec 12; 12(12):CD000551. PubMed ID: 23235576
    [Abstract] [Full Text] [Related]

  • 3. Bisphosphonates for osteoporosis in primary biliary cirrhosis.
    Rudic JS, Giljaca V, Krstic MN, Bjelakovic G, Gluud C.
    Cochrane Database Syst Rev; 2011 Dec 07; (12):CD009144. PubMed ID: 22161446
    [Abstract] [Full Text] [Related]

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P.
    Cochrane Database Syst Rev; 2022 Feb 01; 2(2022):. PubMed ID: 36321557
    [Abstract] [Full Text] [Related]

  • 5. Systematic review and meta-analysis: bezafibrate in patients with primary biliary cirrhosis.
    Yin Q, Li J, Xia Y, Zhang R, Wang J, Lu W, Zhou Y, Zheng Y, Abudumijiti H, Chen R, Chen K, Li S, Liu T, Wang F, Lu J, Zhou Y, Guo C.
    Drug Des Devel Ther; 2015 Feb 01; 9():5407-19. PubMed ID: 26491252
    [Abstract] [Full Text] [Related]

  • 6. Hormone replacement for osteoporosis in women with primary biliary cirrhosis.
    Rudic JS, Poropat G, Krstic MN, Bjelakovic G, Gluud C.
    Cochrane Database Syst Rev; 2011 Dec 07; (12):CD009146. PubMed ID: 22161447
    [Abstract] [Full Text] [Related]

  • 7. Nitazoxanide for chronic hepatitis C.
    Nikolova K, Gluud C, Grevstad B, Jakobsen JC.
    Cochrane Database Syst Rev; 2014 Apr 06; 2014(4):CD009182. PubMed ID: 24706397
    [Abstract] [Full Text] [Related]

  • 8. Ursodeoxycholic acid for primary biliary cirrhosis.
    Gong Y, Huang ZB, Christensen E, Gluud C.
    Cochrane Database Syst Rev; 2008 Jul 16; (3):CD000551. PubMed ID: 18677775
    [Abstract] [Full Text] [Related]

  • 9. Aminoadamantanes for chronic hepatitis C.
    Lamers MH, Broekman M, Drenth JP, Gluud C.
    Cochrane Database Syst Rev; 2014 May 03; 2014(5):CD010125. PubMed ID: 24793264
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pharmacological interventions for primary biliary cholangitis: an attempted network meta-analysis.
    Saffioti F, Gurusamy KS, Eusebi LH, Tsochatzis E, Davidson BR, Thorburn D.
    Cochrane Database Syst Rev; 2017 Mar 28; 3(3):CD011648. PubMed ID: 28350426
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and Safety of Bezafibrate Alone or in Combination with Ursodeoxycholic Acid in Primary Biliary Cholangitis: Systematic Review and Meta-Analysis.
    Khakoo NS, Sultan S, Reynolds JM, Levy C.
    Dig Dis Sci; 2023 Apr 28; 68(4):1559-1573. PubMed ID: 36180756
    [Abstract] [Full Text] [Related]

  • 14. Combination therapy of fenofibrate and ursodeoxycholic acid in patients with primary biliary cirrhosis who respond incompletely to UDCA monotherapy: a meta-analysis.
    Zhang Y, Li S, He L, Wang F, Chen K, Li J, Liu T, Zheng Y, Wang J, Lu W, Zhou Y, Yin Q, Xia Y, Zhou Y, Lu J, Guo C.
    Drug Des Devel Ther; 2015 Apr 28; 9():2757-66. PubMed ID: 26045661
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C.
    Hauser G, Awad T, Brok J, Thorlund K, Štimac D, Mabrouk M, Gluud C, Gluud LL.
    Cochrane Database Syst Rev; 2014 Feb 28; 2014(2):CD005441. PubMed ID: 24585509
    [Abstract] [Full Text] [Related]

  • 17. Effect of bezafibrate in primary biliary cirrhosis: a pilot study.
    Ohmoto K, Mitsui Y, Yamamoto S.
    Liver; 2001 Jun 28; 21(3):223-4. PubMed ID: 11422787
    [No Abstract] [Full Text] [Related]

  • 18. L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis.
    Goh ET, Stokes CS, Sidhu SS, Vilstrup H, Gluud LL, Morgan MY.
    Cochrane Database Syst Rev; 2018 May 15; 5(5):CD012410. PubMed ID: 29762873
    [Abstract] [Full Text] [Related]

  • 19. Acetyl-L-carnitine for patients with hepatic encephalopathy.
    Martí-Carvajal AJ, Gluud C, Arevalo-Rodriguez I, Martí-Amarista CE.
    Cochrane Database Syst Rev; 2019 Jan 05; 1(1):CD011451. PubMed ID: 30610762
    [Abstract] [Full Text] [Related]

  • 20. Ursodeoxycholic acid for primary biliary cirrhosis.
    Gluud C, Christensen E.
    Cochrane Database Syst Rev; 2002 Jan 05; (1):CD000551. PubMed ID: 11869580
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.